Shang-Jui Wang
Impact in
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.5%
- Ferroptosis and cancer prognosis
Papers in
-
- Ferroptosis and cancer prognosis 5
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 3
- Oncology 14
- Cancer-related Molecular Pathways 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Wei Gu (9 shared papers)Le Jiang (7 shared papers)Ning Kon (2 shared papers)Tongyuan Li (2 shared papers)Tao Su (1 shared paper)Richard Baer (1 shared paper)Hanina Hibshoosh (1 shared paper)Yang Ou (6 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Cell Cycle (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cell (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Shang-Jui Wang
30 papers receiving 4.5k citations
Shang-Jui Wang's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 2.8k
- Molecular Biology 2.7k
- Oncology 771
- Biochemistry 131
Countries citing papers authored by Shang-Jui Wang
This map shows the geographic impact of Shang-Jui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang-Jui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang-Jui Wang more than expected).
Fields of papers citing papers by Shang-Jui Wang
This network shows the impact of papers produced by Shang-Jui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang-Jui Wang. The network helps show where Shang-Jui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shang-Jui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis as a p53-mediated activity during tumour suppression Hit paper breakdown → | 2015 | 2660 |
| 2 | Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses Hit paper breakdown → | 2016 | 639 |
| 3 | Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression Hit paper breakdown → | 2016 | 372 |
| 4 | 2015 | 198 | |
| 5 | 2014 | 117 | |
| 6 | 2011 | 107 | |
| 7 | 2008 | 101 | |
| 8 | 2013 | 46 | |
| 9 | 2013 | 45 | |
| 10 | 2020 | 44 | |
| 11 | 2020 | 43 | |
| 12 | 2018 | 29 | |
| 13 | 2018 | 23 | |
| 14 | 2018 | 22 | |
| 15 | 2015 | 20 | |
| 16 | 2019 | 13 | |
| 17 | 2020 | 9 | |
| 18 | 2022 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2023 | 4 |
About Shang-Jui Wang
Shang-Jui Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 33 papers that have together received 4.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (5 papers), Renal cell carcinoma treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (2.8k citations), Molecular Biology (2.7k citations), Oncology (771 citations) and Biochemistry (131 citations). Shang-Jui Wang has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Wei Gu, Le Jiang, Ning Kon, Tongyuan Li, Tao Su, Richard Baer, Hanina Hibshoosh, Yang Ou, Dawei Li and Bo Chu. Their work appears in journals such as Journal of Clinical Oncology, Cell Cycle, Journal of Biological Chemistry, Molecular Cell and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.